Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2019-07-16 5:30 pm Purchase | 13D | UROVANT SCIENCES LTD SHS UROV | Roivant Sciences Ltd. ROIV | 22,860,013 75.4% | 156,344 (+0.69%) | View |
| 2019-07-16 5:30 pm Sale | 13D | AXOVANT GENE THERAPIES LTD COM AXGT | Roivant Sciences Ltd. ROIV | 13,244,047 58.1% | -92,708,334 (-87.50%) | View |
| 2019-07-16 5:30 pm Unchanged | 13D | ARBUTUS BIOPHARMA CORP ABUS | Roivant Sciences Ltd. ROIV | 16,013,540 28.2% | 0 (Unchanged) | View |
| 2019-07-16 5:29 pm Unchanged | 13D | MYOVANT SCIENCES LTD COM MYOV | Roivant Sciences Ltd. ROIV | 40,765,599 45.6% | 0 (Unchanged) | View |
| 2019-06-14 5:01 pm Purchase | 13D | MYOVANT SCIENCES LTD COM MYOV | Roivant Sciences Ltd. ROIV | 40,765,599 45.6% | 2,424,242 (+6.32%) | View |